ArticleAdvances in therapy2026
Incidence, Healthcare Resource Utilization, and Costs Associated with Intraoperative Ureteral Injuries: Evidence from a German Claims Database.
Article in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIntraoperative ureteral injury (IUI) is a serious complication that can result in substantial clinical and economic burdens. This retrospective study evaluated incidence, healthcare resource utilization (HRU), and associated costs among patients with and without IUIs in Germany.
methodsThis descriptive, comparative, longitudinal study included anonymized claims data from the German WIG2 Benchmark Database. Patients aged ≥ 18 years who underwent abdominopelvic surgery with a risk of IUI from 1 January 2014 to 31 December 2021 were included. IUI incidence proportions were calculated overall and by surgery type (gastrointestinal [GI], gynecological [GYN], and other abdominopelvic surgeries). HRU associated with inpatient stays for index hospitalizations and all-cause costs were summarized during the 1-year follow-up.
resultsAmong 159, 581 patients, 217 had IUIs, with an overall incidence proportion of 0.14%. GI procedures accounted for 43.8% of IUIs (incidence proportion 0.10%), GYN for 42.4% (0.16%), and other abdominopelvic procedures for 13.8% (0.28%). Proctectomy (1.03%) and hysterectomy with removal of other structures (0.74%) had the highest IUI incidence proportions. Patients with IUIs had significantly longer mean inpatient stays vs. those without IUIs (19.1 vs. 9.4 days; mean difference 9.6 days; P < 0.001). During the 1-year follow-up, patients with IUIs incurred substantially higher total healthcare costs vs. patients without IUIs (mean €67,041 vs. €38,177; mean difference €28,864; P = 0.001). More patients with IUIs experienced postsurgical inpatient admissions (81.5% vs. 41.2%; P < 0.001) and emergency visits (39.8% vs. 20.8%; P < 0.001) vs. those without IUIs. The increased costs were mainly due to inpatient hospital stays (mean €26,046 vs. €13,600 for patients with vs. without IUIs, respectively; mean difference €12,445; P < 0.001).
conclusionsAlthough relatively rare, patients who experienced IUIs had significantly higher HRU and costs vs. patients without IUIs. Targeted strategies are crucial for reducing IUIs and improving clinical and economic outcomes among at-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.